Biomerica, Inc. (BMRA)
BMRA moved a median of 0.00% 30 minutes after news, and +0.38% by the close. How BMRA actually reacts to news — the realized, point-in-time move the market made, measured across 135 labeled events over the last three years with zero look-ahead.
BMRA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 27% | 117 |
| 30-min | 0.00% | 49% | 131 |
| 60-min | +0.16% | 51% | 135 |
| to close | +0.38% | 50% | 135 |
| Middle 50% of BMRA reactions | -1.64% to +1.65% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 135 |
Half of all Biomerica, Inc. news events land between -1.64% and +1.65% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BMRA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BMRA's baseline. Nothing else.
Recent BMRA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Biomerica Reports First Quarter Fiscal 2027 Financial Results | Press release | GlobeNewswire | +1.91% | +1.09% | |
| Form DEF 14A BIOMERICA INC For: Oct 16 | SEC filing · Form DEF | SEC EDGAR | — | — | |
| Form 10-Q BIOMERICA INC For: Aug 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.91% | +1.09% | |
| Form 8-K BIOMERICA INC For: Oct 09 | SEC filing · Form 8-K | SEC EDGAR | +1.91% | +1.09% | |
| Form EFFECT BIOMERICA INC | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -1.05% | |
| Form 10-K/A BIOMERICA INC For: May 31 | SEC filing · Form 10-K | SEC EDGAR | -2.34% | -2.13% | |
| Form S-3 BIOMERICA INC | SEC filing · Form S-3 | SEC EDGAR | — | +0.43% | |
| Form S-3 BIOMERICA INC | SEC filing · Form S-3 | SEC EDGAR | +0.00% | -4.53% | |
| Biomerica Reports Fiscal 2026 Year-End Financial Results | Press release | GlobeNewswire | -1.85% | -2.79% | |
| Form 10-K BIOMERICA INC For: May 31 | SEC filing · Form 10-K | SEC EDGAR | -1.85% | -2.79% | |
| Biomerica Announces $2.23 Million Financing | Press release | GlobeNewswire | +0.00% | +22.81% | |
| Form 8-K BIOMERICA INC For: Aug 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +22.81% | |
| Form 8-K BIOMERICA INC For: May 29 | SEC filing · Form 8-K | SEC EDGAR | — | +0.95% | |
| Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development | Press release | GlobeNewswire | +0.62% | +0.83% | |
| ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer | Press release | Business Wire | +1.76% | +4.85% | |
| Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 | Press release | GlobeNewswire | — | +0.47% | |
| Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway | Press release | GlobeNewswire | +0.00% | -0.45% | |
| Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs | Press release | GlobeNewswire | +1.98% | +3.45% | |
| Biomerica Reports Third Quarter Fiscal 2026 Financial Results | Press release | GlobeNewswire | +1.98% | +3.45% | |
| Form 10-Q BIOMERICA INC For: Feb 28 | SEC filing · Form 10-Q | SEC EDGAR | +1.98% | +3.45% | |
| Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe | Press release | GlobeNewswire | -0.46% | -0.93% | |
| Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain | Press release | GlobeNewswire | -1.62% | -3.90% | |
| Form S-8 BIOMERICA INC | SEC filing · Form S-8 | SEC EDGAR | -3.92% | +0.49% | |
| Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy | Press release | GlobeNewswire | -0.93% | -5.09% | |
| Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution | Press release | GlobeNewswire | -2.22% | -0.89% | |
| Biomerica Reports Second Quarter Fiscal 2026 Financial Results | Press release | GlobeNewswire | — | +0.38% | |
| Form 10-Q BIOMERICA INC For: Nov 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.38% | |
| Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test | Press release | GlobeNewswire | -1.20% | +4.38% | |
| Form 8-K BIOMERICA INC For: Dec 12 | SEC filing · Form 8-K | SEC EDGAR | — | -2.87% | |
| Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio | Press release | GlobeNewswire | -1.94% | +0.00% | |
| Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS | Press release | GlobeNewswire | -8.22% | +3.46% | |
| Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand | Press release | GlobeNewswire | -1.17% | -0.39% | |
| Form DEFA14A BIOMERICA INC | SEC filing · Form DEFA14A | SEC EDGAR | +0.37% | +2.07% | |
| Form DEF 14A BIOMERICA INC For: Dec 12 | SEC filing · Form DEF | SEC EDGAR | -1.28% | +2.56% | |
| Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. | Press release | GlobeNewswire | -1.26% | +11.48% | |
| Biomerica Reports First Quarter Fiscal 2026 Financial Results | Press release | GlobeNewswire | +0.35% | +0.70% | |
| Form 10-Q BIOMERICA INC For: Aug 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.35% | +0.70% | |
| Form PRE 14A BIOMERICA INC For: Oct 09 | SEC filing · Form PRE | SEC EDGAR | -1.36% | -4.07% | |
| Form 8-K BIOMERICA INC For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.49% | |
| Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors | Press release | GlobeNewswire | +0.00% | +2.49% | |
| Form 10-K/A BIOMERICA INC For: May 31 | SEC filing · Form 10-K | SEC EDGAR | -1.05% | +0.00% | |
| Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes | Press release | GlobeNewswire | +0.37% | +6.20% | |
| United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use | Press release | GlobeNewswire | -3.76% | -10.66% | |
| Biomerica Reports Fiscal 2025 Year End Results | Press release | GlobeNewswire | +0.00% | -0.99% | |
| Form 10-K BIOMERICA INC For: May 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -0.99% | |
| United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use | Press release | GlobeNewswire | -1.67% | -16.23% | |
| InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code | Press release | GlobeNewswire | +0.83% | +6.95% | |
| Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer | Press release | GlobeNewswire | — | +4.92% | |
| Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair | Press release | GlobeNewswire | — | +4.32% | |
| Form 8-K BIOMERICA INC For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.32% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BMRA section they belong to.
Where else BMRA is measured.
BMRA earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kodiak Sciences Inc (KOD) | 138 | +0.09% | 51% |
| Fonar Corporation (FONR) | 137 | 0.00% | 34% |
| BioStem Technologies, Inc. (BSEM) | 135 | +0.30% | 53% |
| Amedisys Inc (AMED) | 134 | -0.01% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Biomerica, Inc.'s median reaction calculated?
Every labeled BMRA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 135 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of BMRA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BMRA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.